Stanford Depression Research Clinic Currently Recruiting for ASCERTAIN-TRD Study

July 31, 2021 | 12:00am - 12:00am

Augmentation versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-Responders with Treatment Resistant Depression (ASCERTAIN-TRD)

The Stanford Depression Research Clinic is seeking people with major depressive disorder (MDD) to participate in a new research study.  If you are between the ages of 18 and 80, currently depressed, and have a history of trying at least one antidepressant medication, you may be eligible.

This study involves comparing three treatment arms:

  • Adding Abilify to current antidepressant medication
  • Adding Repetitive Transcranial Magnetic Stimulation (rTMS) to current antidepressant medication
  • Switching your current antidepressant medication to Effexor Extended Release or Cymbalta

These three treatments are approved by the FDA to treat TRD. If enrolled, this study involves 9 visits over 12 weeks.

If you are currently taking an antidepressant medication that is only partially helping your depression, please fill out our online survey or email

For further details, please see the following link:

Full event information:

Location: 401 Quarry Road, Stanford CA

Contact Email: